Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

Seung, Kwonjune J., Keshavjee, Salmaan, Rich, Michael L.·2015·Cold Spring Harbor Perspectives in Medicine

DOI 10.1101/cshperspect.a017863

Cited by (803)

Items 301–400 of 803

Advances in spray drying technology for anti-tubercular formulation development: A comprehensive review
Eknath B. Kole, Krishna Jadhav, Yogesh Ashok Sonar, Mayur Kapse, Shripad A. Patil, Amit Kumar Singh, Satish V. Rojekar, Rahul Kumar Verma, ARUN SADASHIV MUJUMDAR, Jitendra Naik · 2025 · Drying Technology
A long journey to be diagnosed as a case of tuberculous cystitis: A Bangladeshi case report and review of literatures
Mainul Haque, Tajkera Sultana Chowdhury, MdFazal Naser · 2020 · International Journal of Mycobacteriology
Controversies and Pitfalls in the Diagnosis of Extrapulmonary Tuberculosis with a Focus on Genital Tuberculosis
Nalini Mahajan · 2020 · US Endocrinology
Bifurcation analysis of a model of tuberculosis epidemic with treatment of wider population suggesting a possible role in the seasonality of this disease
Mohammed-Salah Abdelouahab, Ahlam Arama, René Lozi · 2021 · Chaos An Interdisciplinary Journal of Nonlinear Science
Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases
Dhananjay Yadav, Peninah M. Wairagu, Minseok Kwak, Jun-O Jin · 2022 · Current Drug Metabolism
Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia
Mohamed Muhumed Ali, Fitsum Weldegebreal, Getachew Kabew, Kedir Urgesa · 2023 · SAGE Open Medicine
Development of bedaquiline nanoemulsions intended for paediatric multidrug-resistant tuberculosis: excipient selection and preformulation studies
Taiwo Oreoluwa Ajayi, Madan Poka, Bwalya Angel Witika · 2024 · Frontiers in Medical Technology
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques
Hazem F. M. Abdelaal, Bryan J. Berube, Brendan K. Podell, Matthew H. Harband, Hadley E. Gary, Martin Perez-Jaimes, David Forrest Ackart, Valerie A. Reese, Sasha E. Larsen, Tiffany Pecor et al. · 2024 · npj Antimicrobials and Resistance
The power of DNA-encoded chemical libraries in the battle against drug-resistant bacteria
Riyad E. Sibai, Zainab E. M. Farahat, Hasnaa H. Qasem, Haitham Hassan · 2025 · RSC Advances
Nanoparticles as an Alternative Strategy for the Rapid Detection of Mycobacterium tuberculosis Complex (MTBC): A Systematic Literature Review of In Vitro Studies
Abayeneh Girma, Fentaye Kassawmar, Yeshiwas Kassa, Yeshwas Asrat · 2025 · IET Nanobiotechnology
Design, Synthesis, Biological Evaluation, and Computational Studies of Pyrazine‐1,3,4‐Oxadiazole Analogs as Potential Antitubercular Agents
Asha Ganesh Suryawanshi, Chandni Pathak, Pratik Khona, Ashish Jain, Uma Dhiraj Kabra · 2025 · Chemistry & Biodiversity
Exploring Problematizations Underlying Tuberculosis Control Strategies: A Cross-Country Analysis of India and Kenya
GK Mini, Sapna Mishra, Jinbert Lordson, Malu Mohan · 2023 · Integrated science
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus
Jeremy J. Yang, Aaron Goff, David J. Wild, Ying Ding, Ayano Annis, Randy Kerber, Brian Foote, Anurag Passi, Joel L. Duerksen, Shelley London et al. · 2024 · Tuberculosis
Integrated Public-Private Partnerships to Combat Tuberculosis for Improving Economic Development
S. Srinivasan, R. Vallipriya, Ajay Kumar Singh · 2025 · IGI Global eBooks
Epidemiologia global de pacientes com tuberculose multidrogarresistente (MDR-TB) e extensivamente resistente (XDR-TB)
Jorge Del Arco, Naiara Cristina Ule Belotti, Naidy Konno Madela, Rosângela Siqueira de Oliveira, Heloisa da Silveira Paro Pedro · 2018 · Clinical & Biomedical Research
Anti-Tubercular Activity of Pyrazinamide Conjugates: Synthesis and Structure-Activity Relationship Studies
Simranpreet K. Wahan, Sangeeta Sharma, Pooja A. Chawla · 2022 · Mini-Reviews in Medicinal Chemistry
Synthesis and Biological Activities of Some 1,2,4-Triazole Derivatives: A Review
Dina Saleem M. Ameen, Mohammed Dheyaa Al-Ameedee, Ayad Kareem Khan · 2022 · Al Mustansiriyah Journal of Pharmaceutical Sciences
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Betty R. Mchaki, Fauster X. Mgaya, Peter Ponsian Kunambi, Mecky Isaac Matee · 2023 · Bulletin of the National Research Centre/Bulletin of the National Research Center
Improving Nurses’ Knowledge, Practice, and Self-Efficacy Regarding Caring Patients with Tuberculosis: A Quasi-Experimental Design
Samia Eaid Elgazzar, Mirfat Mohamed Labib Elkashif, Mohamed Goda Elbqry, Fatma Mohamed Elmansy · 2023 · Iranian Journal of Nursing and Midwifery Research
Effects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope
Fabian M. Meyer, Urska Repnik, Ekaterina Karnaukhova, Karin Schubert, Marc Bramkamp · 2023 · The Cell Surface
Vitamin D as Supplementary Treatment for Newly Diagnosed Pulmonary Tuberculosis patients
Yatish Byndoor, Tamilisetti Vidya Sagar, Raju Hanumant Patil, Dakkumalla Veeraiah · 2023 · Research Journal of Pharmacy and Technology
Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for Mycobacterium tuberculosis
Padam Singh, Arun Kumar, Pankaj Sharma, Saurabh Chugh, Ashish Kumar, Nidhi Sharma, Sonu Kumar Gupta, Manisha Singh, Saqib Kidwai, Jishnu Sankar et al. · 2024 · Antimicrobial Agents and Chemotherapy
Recent advances in tuberculosis: A comprehensive review of emerging trends in pathogenesis, diagnostics, treatment, and prevention
Abdullah Salim Al-Karawi, Afraa Ali Kadhim, Maha M. Kadum · 2024 · International Journal of Clinical Biochemistry and Research
Development and emerging trends of drug resistance mutations in HIV: a bibliometric analysis based on CiteSpace
Xuannan Chen, Xi Chen, Yu Liang Lai · 2024 · Frontiers in Microbiology
Multidirectional Benefits of Nanotechnology in the Diagnosis, Treatment and Prevention of Tuberculosis
Monika Gupta, Shivangi, Laxman S. Meena · 2020 · Journal of Nanotechnology and Nanomaterials
Tuberculous Scleritis and Multidrug Resistance
Mamta Agarwal, Gazal Patnaik, Shweta Agarwal, Geetha Krishnan Iyer, Appakkudal R. Anand, Gayathri Ar, Jyotirmay Biswas, Manfred Zierhut · 2021 · Ocular Immunology and Inflammation
Fidaxomicin has high in vitro activity against Mycobacterium tuberculosis
Qing Sun, Shuqi Wang, Xinlei Liao, Guanglu Jiang, Hairong Huang, Hao Li, Guirong Wang · 2021 · Journal of Medical Microbiology
Coumarin as a Privileged and Medicinally Important Scaffold in the Treatment of Tuberculosis
Vaibhav Gupta, Ramesh Ambatwar, Neeru Bhanwala, Gopal Lal Khatik · 2023 · Current Topics in Medicinal Chemistry
Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis
Sakshi Patel, Malti Dadheech, Anand Kumar Maurya, Jitendra Singh, Shashank Purwar, Nirendra Kumar Rai, Radha Sarawagi, Ankur Joshi, Sagar Khadanga · 2023 · Cureus
Development of Mycobacterium tuberculosis Enoyl Acyl Reductase (InhA) Inhibitors: A Mini-Review
Navin Kumar Tailor, Geeta Deswal, Kumar Guarve, Ajmer Singh Grewal · 2024 · Mini-Reviews in Medicinal Chemistry
Bactericidal activity of ZnO nanoparticles–anti-TB drug combination towards the H37Rv strain and multidrug-resistant isolates of Mycobacterium tuberculosis via SufB splicing inhibition
Debika Ojha, Ashwaria Mehra, Sunil Swick Rout, Sidhartha Giri, Sasmita Nayak · 2025 · Materials Advances
Comprehensive analysis of tuberculosis burden trends and attributable risk factors in the BRICS countries from 1990 to 2021, with forecasts for the next 15 years
Xiaomeng Zhang, Manru Guo, Xuefei Song, Abualgasim Elgaili Abdalla, Guirong Wang, Longxiang Xie · 2025 · International Journal of Surgery
Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice
H. Manisha Yapa, Emily Lai-Ho MacLean, Nicolas A. Menzies, Peter J. Dodd, Anna S Dean, Fuad Mirzayev, Samuel G. Schumacher, Linh Nhat Nguyen, Matteo Zignol, Greg James Fox · 2025 · Clinical Microbiology Reviews
Trends and treatment outcomes of drug resistant tuberculosis in Limpopo Province, South Africa (2011–2019): A Retrospective Study
Kabelo Gabriel Kaapu, Ivy Rukasha · 2025 · PLoS ONE
Nanoparticle theranostics for respiratory diseases: advances and challenges in asthma, lung cancer, and tuberculosis
Hossein Feyzbakhsh · 2025 · Egyptian Journal of Bronchology
Drug Resistance in Tuberculosis: Nanomedicines at Rescue
Nitendra Kumar, Bhaskar Das, Sanjukta Patra · 2017 · Elsevier eBooks
2 Receptor Specific Ligand Conjugated Nanocarriers: An Effective Strategy for Targeted Therapy of Tuberculosis
Sujata Pralhad Sawarkar, Pratiksha Prabhu, Trinette Fernandes, Mansi Damani, Pramila Chaubey, Shridhar Narayanan · 2021 · Current Drug Delivery
Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study
Philomina Afful, Godwin Adjei Vechey, Peter Kipo Leta, Foster Bediako Gbafu, Fortress Yayra Aku · 2023 · PLoS ONE
Association between HIV and acquisition of rifamycin resistance with first-line TB treatment: a systematic review and meta-analysis
Nesbert Zinyakatira, Nathan Paul Ford, Helen Suzanne Cox · 2024 · BMC Infectious Diseases
The Prevalence of Mycobacterium Tuberculosis Infection in Saudi Arabia: A Systematic Review and Meta-analysis
Badria Said, Amal Hashem Mohamed, Ebtihal Eltyeb, Raga Eltayeb, Nagla Abdalghani, Bahja Siddig, Amel Eltahir Banaga Ahmed, Anwar Balla Eltom Ali, Abdulaziz Alhazmi · 2024 · Journal of Epidemiology and Global Health
Integrative exploration of 2-phenylquinolin-4(1H)-one tethered 1,2,3-triazole derivatives: A comprehensive in vitro and in silico investigation towards novel anti-tubercular agents
Raut Mehavi, Vinayak S. Walhekar, Patil Ashwini, Pavan Kumar Jaini, Mohana Vamsi Nuli, Bhikshapathi DVRN, Ravindra Kulkarni · 2025 · Tuberculosis
Structural insights into PKS13 Thioesterase inhibitors targeting Mycobacterium tuberculosis for drug-resistant tuberculosis therapy: Identification, stability assessment, and pharmacophore modeling
Zia ur Rehman, Hassan A. Alhazmi, Mohammed Albratty, Abdullah A. Algaissi, Hafiz Antar Makeen, Asim Najmi, Khalid A. Zoghebi, Sivakumar S. Moni, Siddig İbrahim Abdelwahab, Manal Mohamed Elhassan Taha et al. · 2025 · Results in Chemistry
Interaction of Host Pattern Recognition Receptors (PRRs) withMycobacterium Tuberculosisand Ayurvedic Management of Tuberculosis: A Systemic Approach
Nirmaladevi Ponnusamy, Mohanapriya Arumugam · 2021 · Infectious Disorders - Drug Targets
Screening and Identification of a Novel Anti-tuberculosis Compound That Targets Deoxyuridine 5′-Triphosphate Nucleotidohydrolase
Yu Zhang, Hongjuan Zhang, Ying Chen, Luyao Qiao, Yanxing Han, Yuan Lin, Shuyi Si, Jian‐Dong Jiang · 2021 · Frontiers in Microbiology
Nonadherence Predictors to Tuberculosis Medications among TB Patients in Gambella Region of Ethiopia
Taye Kebede, Wiw Gach Jing, Abiot Girma, Kifle Woldemichael · 2022 · Canadian Journal of Infectious Diseases and Medical Microbiology
Factors Associated of Multidrug-Resistance Tuberculosis among Minangkabau Ethnicity in Indonesia
Ambun Kadri, Rizanda Machmud, Andani Eka Putra, Ahmad Syafruddin Indrapriyatna · 2022 · Open Access Macedonian Journal of Medical Sciences
A multidimensional approach to the elimination of tuberculosis
Neha Singh, Khushboo Bhange · 2022 · Journal of Bacteriology & Mycology Open Access
Harnessing CRISPR-Cas9 as an anti-mycobacterial system
Megha Sodani, Chitra Seetharam Misra, Devashish Rath, Savita Kulkarni · 2023 · Microbiological Research
COMBATING THE ANTIMICROBIAL RESISTANCE BY PERSONALIZED MEDICINE: A MINI-REVIEW
Shrikant Verma, Sushma Verma, Mohammad Abbas, Farzana Mahdi · 2023 · Era s journal of medical research
A qualitative exploration of challenges in childhood TB patients identification and diagnosis in Bangladesh
Sharmin Akter Shitol, Avijit Saha, Mrittika Barua, Kazi Md Saleheen Towhid, Akramul Islam, Malabika Sarker · 2023 · Heliyon
Therapeutic Modulation of Arginase with nor-NOHA Alters Immune Responses in Experimental Mouse Models of Pulmonary Tuberculosis including in the Setting of Human Immunodeficiency Virus (HIV) Co-Infection
Sadhana Chauhan, Rebecca J. Nusbaum, Matthew B. Huante, Alex J. Holloway, Mark A. Endsley, Benjamin B. Gelman, Joshua G. Lisinicchia, Janice Jones Endsley · 2024 · Tropical Medicine and Infectious Disease
Clofazimine inhibits innate immunity against Mycobacterium tuberculosis by NF-κB
Xinda Li, Xiaoyi Luo, Bin Wang, Lei Fu, Xi Chen, Yu Lu · 2024 · mSphere
Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report
Bugwesa Z. Katale, Sylvia Rofael, Linzy Elton, Erasto Vitus Mbugi, Stellah George Mpagama, Daphne Mtunga, Maryjesca G. Mafie, Peter M. Mbelele, Charlotte A. Williams, Happiness Mvungi et al. · 2024 · Annals of Clinical Microbiology and Antimicrobials
Effective Reproduction Number of Smear-Positive Pulmonary Tuberculosis in Iran: A Registry-Based Study (2011-2021)
Maryam Rastegar, Vahid Fakoor‎, Eisa Nazar, Mahshid Nasehi, Saeed Sharafi, Mohammad Taghi Shakeri · 2024 · Journal of Research in Health Sciences
THE DETECTION OF EPIDEMIC SUBTYPES OF BEIJING GENOTYPE OF MYCOBACTERIUM TUBERCULOSIS CIRCULATED IN THE PRIMORSKY KRAI
Хромова Полина Андреевна, M. S. Kornilov, Жданова Светлана Николаевна, Anatoly A. Yakovlev, О. Б. Огарков · 2018 · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
Tuberculosis con resistencia a rifampicina en Chile
Carlos Peña M., Nadia Escobar S. · 2021 · Revista chilena de enfermedades respiratorias
Excellent synergistic activity of a designed membrane acting pyridinium containing antimicrobial cationic N -acylethanolamine with isoniazid against mycobacterium
Siva Bala Subramaniyan, Sengan Megarajan, Subburethinam Ramesh, Anbazhagan Veerappan · 2021 · New Journal of Chemistry
The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis
Azhar Iqbal, Muhammad Waleed Shafique, Muhammad Asif Zahoor, Saima Muzammil, Zeeshan Nawaz, Abdul Jabbar, Mohsin Khurshid, Riaz Hussain, Md. Akhtarul Islam, Ahmad Almatroudi et al. · 2022 · The Journal of Infection in Developing Countries
Niosomes in Tuberculosis
Geeta K. Patel, Bhupendra Gopalbhai Prajapati, Yashwant Vishnupant Pathak · 2023 · Springer eBooks
Brain Tuberculosis: An Odyssey through Time to Understand This Pathology
Raluca Elena Patrascu, Andrei Ionuț Cucu, Claudia Florida Costea, Mihaela Coșman, Laurenţiu Andrei Blaj, Adriana Hristea · 2023 · Pathogens
Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains
Silvia Bua, Alessandro Bonardi, Georgiana Ramona Mük, Alessio Nocentini, Paola Gratteri, Claudiu Trandafir Supuran · 2024 · International Journal of Molecular Sciences
Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates
Riya Madan, Kushankur Pandit, Lavi Bhati, Hindesh Kumar, Neha Kumari, Swati Singh · 2021 · Microbial Pathogenesis
Immunoinformatics Prediction of Epitope Based Peptide Vaccine Against Mycobacterium Tuberculosis PPE65 family Protein
Mustafa Elhag, Anfal Osama Mohamed Sati, Moaaz Mohammed Saadaldin, Mohammed Abd El Malik Hassan · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Selected Medicinal Plants Used in the Treatment and Management of Tuberculosis and Related Symptoms in South Africa
Makosha Patience Mamabolo, Babalwa Tembeni, Xavier Siwe‐Noundou, Nontobeko P. Mncwangi · 2025 · Pharmaceuticals
Suppressing lipid biosynthesis in Mycobacterium tuberculosis through polyketide synthase 13 thioesterase inhibition: Insights from computational analysis
Maha Alawi, Hattan S. Gattan, Azzah S. Alharbi, Mohammed H. Alruhaili, Ibrahim Alzahrani, Saad B Al Masaud, Vivek Dhar Dwivedi, Esam I. Azhar · 2025 · Journal of Infection and Public Health
Docking and AI-based classification cum recurrent neural network validation for predicting anti-tubercular leads against dprE-1 enzyme targeter
Isha Garg, Kandasamy Nagarajan, Snigdha Bhardwaj, Arun Kumar Tripathi, Apoorv Jain, Vidhu Saxena · 2025 · Current Proteomics
Immune profiles of immune checkpoint molecules on peripheral T cells in multidrug resistant-tuberculosis
Xiaoxu Yang, Lan Yao, Xuwei Gui, Yangdian Lai, Ping Ji, Ying Wang, Yingying Chen, Wei Sha · 2025 · International Journal of Infectious Diseases
Investigating the geographic linkage between airborne pollutants and tuberculosis rates in India
Vijay Kumar, Tulika Tripathi, Alok Raj, Pradeep Kumar · 2025 · Discover Public Health
Machine Learning–Driven discovery of mushroom-derived inhibitors targeting InhA of Mycobacterium tuberculosis: An integrated QSAR, molecular docking and molecular dynamic simulation approach
Karma Wangchuk, Mudassar Fareed Awan, Syeda Nazish Sohaib, Abdul Basit, Prince Danan Biniyam, Laiba Nadeem, Abdelkrim Guendouzi, Aisha Khalid, Khursheed Muzammil · 2025 · Journal of Molecular Graphics and Modelling
Antibiotic Alternative Strategies Against Aeromonas hydrophila Infections: New Trends and Advances
Shengping Li, Jing Dong, Shun Zhou, Bo Cheng, Xiaohui Ai · 2025 · Reviews in Aquaculture
Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis
Siti Soidah, Toto Subroto, Irvan Faizal, M. Farhan Yusuf · 2025 · Pathogens
Autophagy as a Target for Host-Directed Therapy Against Tuberculosis
Surbhi Verma, Raman Deep Sharma, Dhiraj Kumar · 2020 · Springer eBooks
Cytotoxicity and gene expression studies in understanding the mechanism on antimycobacterial properties of methanolic leaf extract of Acalypha indica Linn.
Kanika Kisku, Hrudananda Sahoo, Bhaskar Chandra Sahoo, Sunil Swick Rout, Nabendu Murmu, Umesh Chandra Naik · 2023 · South African Journal of Botany
Assessment of Knowledge, Attitude, Practice and Medication Adherence among Tuberculosis Patients in Tertiary Care Hospital
Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy, Akash Chathamvelli, Kadambari Patil, Anirudh. Pai, Aditi Baadkar · 2023 · International Journal of Pharmaceutical Investigation
Inhibiting the oligomerization of mycobacterial DNA-directed RNA polymerase (RNAP) using natural compound via in-silico techniques
Ehssan H. O. Moglad · 2024 · Medicine in Novel Technology and Devices
Structure-guided identification and characterization of potent inhibitors targeting PhoP and MtrA to combat mycobacteria
Han-Li Su, Shu-Jung Lai, Keng‐Chang Tsai, Kit-Man Fung, Tse-Lin Lung, Hsing-Mien Hsu, Yichen Wu, C.Q. Liu, Hui-Xiang Lai, Jiun-Han Lin et al. · 2024 · Computational and Structural Biotechnology Journal
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Multidrug-Resistant Mycobacterium tuberculosis in Jiangxi, China
Jingnan Zhao, Chengyu Qian, Youqiao Jiang, Wangrui He, Weixi Wu · 2024 · Infection and Drug Resistance
Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3
Amit Kumar Verma, Robbert Q. Kim, Dirk A. Lamprecht, Clara Aguilar-Pérez, Sarah Wong, Nicolas Véziris, Alexandra Aubry, José Manuel Bartolomé-Nebreda, Rodrigo J. Carbajo, Jennefer Wetzel et al. · 2025 · npj Drug Discovery.
Identification of Gene Expression Biomarkers Predictive of Latent Tuberculosis Infection Using Machine Learning Approaches
Youssra Boumait, Boutaina Ettetuani, Manal Chrairi, Afaf Lamzouri, Rajaa Chahboune · 2025 · Genes
Fitness Effect of the Isoniazid Resistance Mutation S315T of the Catalase-Peroxidase Enzyme KatG of Mycobacterium tuberculosis
Ugo Bastolla, Mikhail Rotkevich, Miguel Arenas, Manuel Arrayás, Марине Зауриевна Догонадзе, Anastasia I. Lavrova, Jorge Molina-Sejas, Michaël D. Tadesse, Ramón Xulvi-Brunet, Jonathan A. G. Cox et al. · 2025 · Genome Biology and Evolution
Metformin and Rifampicin combination augments active to latent tuberculosis conversion: A computational study
Deepak Yadav, Sumanpreet Kaur, Dibyajyoti Banerjee, Rajasri Bhattacharyya · 2020 · Biotechnology and Applied Biochemistry
Recent Discoveries of Nitrogen-Containing Heterocyclic Compounds as InhA Inhibitors against Mycobacterium tuberculosis: An Overview
Pratibha D. Gupta, Kalpana N. Tilekar, Neha Upadhyay, C. S. Ramaa · 2022 · Infectious Disorders - Drug Targets
Amyloid deposition in granuloma of tuberculosis patients: A single-center pilot study
Shreya Ghosh, Chayanika Kala, Akansha Garg, Ashwani Kumar Thakur · 2022 · Tuberculosis
Interleukin 18 and interleukin 22 as important immune markers in patients with tuberculosis
Firas Mohammad Hussein Kamoona, Ahmed Abduljabbar Jaloob Aljanaby · 2023 · E3S Web of Conferences
Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics
Nicole F. Maranchick, Awewura Kwara, Charles A. Peloquin · 2024 · Expert Review of Clinical Pharmacology
Machine Learning Approaches for Suicidal Ideation Detection on Social Media
B Nandhini, Jayanthi, K Shrinivas, Priya Vinod · 2023 · International Conference on Computation, Automation and Knowledge Management (ICCAKM)
Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosis
Hagyu Kim, Eun-Jung Song, Eunsol Choi, Kee Woong Kwon, Jong‐Hwan Park, Sung Jae Shin · 2024 · International Immunopharmacology
Fecal microbiota transplantation: A potential novel treatment strategy for extensively drug-resistant tuberculosis
Seyed Aria Nejadghaderi, Alexander L. Chu · 2024 · Medical Hypotheses
The impact of living conditions and health interventions on tuberculosis, Denmark, 1876 to 2022
Anne Christine Nordholm, Anja Jørgensen, Louise Hedevang Holm, Åse Bengård Andersen, Anders Koch, Peter Henrik Andersen, Troels Lillebæk · 2024 · Eurosurveillance
N-Acyl phenothiazines as mycobacterial ATP synthase inhibitors: Rational design, synthesis and in vitro evaluation against drug sensitive, RR and MDR-TB
Rajkumar Reddyrajula, Summaya Perveen, Anjali Negi, Umadevi Etikyala, Vijjulatha Manga, Rashmi Sharma, Udayakumar Dalimba · 2024 · Bioorganic Chemistry
A rapid and simple modified nitrate reductase assay for testing first and second-line antituberculosis drug susceptibilities in Mycobacterium tuberculosis isolates
Ece Şimşek, Kübra Yıldırım, Cemilenur Ataş, Ahmet Yılmaz Çoban · 2024 · Diagnostic Microbiology and Infectious Disease
Interleukin-26 expression in tuberculosis disease and its regulatory effect in macrophage polarization and intracellular elimination of Mycobacterium tuberculosis
Kaisong Huang, Haijin Zhou, Mei Chen, Rui Chen, Xiaoping Wang, Qi Chen, Zhiyun Shi, Yanfang Liang, Luxin Yu, Ping Ouyang et al. · 2024 · Frontiers in Cellular and Infection Microbiology
Thiosemicarbazone Derivatives in Search of Potent Medicinal Agents: QSAR Approach (A Review)
Mohammad I. Ahmad, Ekhlakh Veg, Seema Joshi, Abdul Rahman Khan, Tahmeena Khan · 2024 · Russian Journal of General Chemistry
Active- and Allosteric-Site Cyclic Peptide Inhibitors of Secreted M. tuberculosis Chorismate Mutase
Renier H. P. van Neer, Patricia K. Dranchak, Mahesh Aitha, Lijun Liu, Emma K. Carlson, Isabella E. Jacobsen, K.P. Battaile, Yuhong Fang, Dingyin Tao, Ganesha Rai et al. · 2025 · ACS Infectious Diseases
Prevalence and Genetic Profiling of Second-line Drug Resistant Tuberculosis at the Tertiary Care Center of Northern India
Nandini Singh, Amresh Kumar Singh, Sushil Kumar, Akanksha Chaudhary, Ashwini Kumar Mishra, Narendra Pratap Singh · 2025 · Current Microbiology
A review of the human microRNA and the Mycobacterium tuberculosis epigenetic effects on the emergence drug resistance
Yashna Sukdeo, Nozibusiso Pearl Shozi, Nonsikelelo Ndimande, Kingsley C. Mbara, Peter M. O. Owira · 2025 · Life Sciences
Extrapulmonary Tuberculosis is the Leading Presentation among Hospitalized Children: A Single-Center Experience in a Decade
Christine William Shaker Basanti, Sonia A. El-Saiedi, Mai Moawad, Azza K. Abdelmegeid · 2021 · Pediatric Sciences Journal
Synthesis and Antimycobacterial Activity of Isoniazid Derivatives Tethered with Aliphatic Amines
Václav Pflégr, Jiřina Stolaříková, Jarmila Vinšová, Martin Krátký · 2022 · Current Topics in Medicinal Chemistry
Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization
Gebeyehu Assefa, Kassu Desta, Shambel Araya, Selfu Girma, Elena Hailu, Adane Mihret, Tsegaye Hailu, Melaku Tilahun, Getu Diriba, Biniyam Dagne et al. · 2023 · Tuberculosis Research and Treatment
Diagnostic accuracy of gold nanoparticle combined with molecular method for detection of Mycobacterium tuberculosis: A systematic review and meta-analysis study
Sepide Kadivarian, Mosayeb Rostamian, Sara Kooti, Ramin Abiri, Amirhooshang Alvandi · 2023 · Sensing and Bio-Sensing Research